FindTrial
Sign In

Effect of Madhunashini Vati Extra Power in Diabetes Mellitus

Effectiveness Assessment of Madhunashini Vati Extra Power in Type 2 Diabetes Mellitus: Prospective, Open Label, Single Arm, Observational Study - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/089660
Enrollment
40
Registered
2025-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil

Sponsors

Patanjali Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HbA1C between 5.7 to 6.4 The subject is able and willing to provide consent

Exclusion criteria

Exclusion criteria: Patients with Type 1 Diabetes Mellitus or on Insulin Patients with Gestational diabetes Pregnancy or lactation planning for pregnancy Patients with uncontrolled HTN Any condition the investigator identifies that can confound the participants ability to participate in the study properly

Design outcomes

Primary

MeasureTime frame
Change in HbA1CTimepoint: baseline (Day 1) to Day 90—

Secondary

MeasureTime frame
Changes in The Revised Version of DQOL RV DQOL13 QuestionnaireTimepoint: baseline (Day 1) to Day 90—

Countries

India

Contacts

Public ContactDr Anurag Sharma

Patanjali Yoggram Yog Naturopathy Panchkarma Treatment and Research Centre

dr.anuragsharma1987@gmail.com08171510464

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026